Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Pemfibrate"'
Autor:
Carl J. Lavie, Salim S. Virani, Wilbert S. Aronow, Manasvi Gupta, Raktim K. Ghosh, Kausik K. Ray, Colin Blumenthal, Vardhmaan Jain, Subhankar Chatterjee, Dhrubajyoti Bandyopadhyay
Publikováno v:
Expert opinion on investigational drugs. 29(6)
INTRODUCTION: Recent years have brought significant developments in lipid and atherosclerosis research. Although statins are a cornerstone in hyperlipidemia management, new non-statin therapies have had an impact. The reduction of low-density lipopro
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Xu, Jiashan, Ashjian, Emily
Publikováno v:
Journal of Pharmacy Practice; Jun2023, Vol. 36 Issue 3, p650-661, 12p
Autor:
Zivkovic, Stefan, Maric, Gorica, Cvetinovic, Natasa, Lepojevic-Stefanovic, Danijela, Bozic Cvijan, Bojana
Publikováno v:
Nutrients; Mar2023, Vol. 15 Issue 6, p1517, 22p
Publikováno v:
South African Medical Journal, Vol 108, Iss 4, Pp 262-265 (2018)
Cardiovascular disease (CVD) remains a major cause of death worldwide, with dyslipidaemia playing a significant role in the disease process. It is clinically useful to demarcate hypercholesterolaemia from hypertriglyceridaemia, with an increased seru
Externí odkaz:
https://doaj.org/article/7388519327cd40dca50b3f56281ac136
Autor:
Brozin, D., Raal, F. J.
Publikováno v:
SAMJ: South African Medical Journal; Apr2018, Vol. 108 Issue 4, p262-265, 4p
Autor:
Frederick J. Raal, D Brozin
Publikováno v:
South African Medical Journal, Vol 108, Iss 4, Pp 262-265 (2018)
Cardiovascular disease (CVD) remains a major cause of death worldwide, with dyslipidaemia playing a significant role in the disease process. It is clinically useful to demarcate hypercholesterolaemia from hypertriglyceridaemia, with an increased seru
Autor:
Ntusi, Ntobeko
Publikováno v:
SAMJ: South African Medical Journal; Apr2018, Vol. 108 Issue 4, p256-257, 2p